Half of the 46,000 employees at Goldman Sachs have access to AI, and CIO Marco Argenti expects more will tap into the ...

Navina, a market leader in AI-powered clinical intelligence, today announced the successful completion of a $55 million Series C funding round, bringing the total funding to $100 million. The round is ...

Artificial intelligence has already made its mark in commercial industries, and there's a good argument to be made that AI is most impactful in the drug discovery marketplace: — Goldman ...

Israeli AI-powered clinical intelligence company Navina has announced the completion of a $55 million Series C financing ...

The Goldman Sachs Group, Inc., a financial institution ... It operates through Global Banking & Markets, Asset & Wealth Management, and Platform Solutions segments. The Global Banking & Markets ...

Half of the 46,000 employees at Goldman Sachs now have access to ... Broader use of generative AI within the company came with the launch of GS AI Assistant, which rolled out last year and has ...

Investment will fuel the advancement of its AI-powered clinical intelligence ... and the CB Insights Digital Health 50 list. Goldman Sachs (NYSE: GS) is one of the leading investors in ...

The round is led by Growth Equity at Goldman Sachs Alternatives ... We believe Navina's AI-powered platform is a game-changer, and we are excited to support their next stage of growth." ...